Why genetically modified mosquitos won't work in fighting malaria

Using CRISPR to genetically modify insects as a way to fight disease or crop devastation may be more difficult than initially thought, due in part to genetic variation within insect populations.

The research, published in the journal Science Advances, combines advanced genetic and statistical analyses to show how certain genetic and behavioral qualities in disease-carrying insects, like mosquitoes, make these species resistant to genetic manipulation.

This resistance could complicate attempts to use CRISPR-Cas9 in the fight against malaria or crop blights such as the western corn rootworm, an invasive species that costs the United States about $1 billion in lost crops each year.

The discovery of the CRISPR-Cas9 system—or simply “CRISPR”—in the early 2010s introduced an unprecedented level of accuracy in genetic editing. Scientists can use the method to design highly precise genetic “scissors” that snip out and replace specific parts of the genome with sequences of their choosing. Two English scientists were the first to show the method could spread infertility in disease-carrying mosquitoes in late 2015.

“We found that small genetic variation within species—as well as many insects’ tendency to inbreed—can seriously impact the effectiveness of attempts to reduce their numbers using CRISPR technology,” says Michael J. Wade, a biology professor at Indiana University, Bloomington. “Although rare, these naturally occurring genetic variants resistant to CRISPR are enough to halt attempts at population control using genetic technology, quickly returning wild populations to their earlier, ‘pre-CRISPR’ numbers.”

This means costly and time-consuming efforts to introduce genes that could control insect populations—such as a trait that causes female mosquitoes to lay fewer eggs—would disappear in a few months. This is because male mosquitoes—used to transmit new genes since they don’t bite—only live about 10 days.

The protective effect of naturally occurring genetic variation is strong enough to overcome the use of “gene drives” based on CRISPR-based technology—unless a gene drive is matched to the genetic background of a specific target population, Wade adds. Gene drives refer to genes that spread at a rate of nearly 90 percent—significantly higher than the normal 50 percent chance of inherence that occurs in sexually reproducing organisms.

Wade, an expert in “selfish genes” that function similarly to gene drives due to their “super-Darwinian” ability to rapidly spread throughout a population, teamed up with colleagues to explore the effectiveness of CRISPR-based population control in flour beetles, a species estimated to destroy 20 percent of the world’s grain after harvest.

The team designed CRISPR-based interventions that targeted three segments in the genome of the flour beetle from four parts of the world: India, Spain, Peru, and Indiana. They then analyzed the DNA of all four varieties of beetle and found naturally occurring variants in the targeted gene sequence, the presence of which would impact the effectiveness of the CRISPR-based technology.

The analysis revealed genetic variation in all four species at nearly every analyzed DNA segment, including a variance rate as high as 28 percent in the Peruvian beetles. Significantly, Wade’s statistical analysis found that a genetic variation rate as low as 1 percent—combined with a rate of inbreeding typical to mosquitos in the wild—was enough to eliminate any CRISPR-based population-control methods in six generations.

The results suggest that a careful analysis of genetic variation in the target population must precede efforts to control disease-carrying insects using CRISPR technology. They also suggest that the unintended spread of modified genes across the globe is highly unlikely since typical levels of genetic variation place a natural roadblock on spread between regions or species.

“Based on this study, anyone trying to reduce insect populations through this method should conduct a thorough genetic analysis of the target gene region to assess variation rates,” Wade says. “This will help predict the effectiveness of the method, as well as provide insight into ways to circumvent natural genetic variation through the use of Cas9 variants with an altered sequence specificity.”

The National Institutes of Health and National Science Foundation supported this study in part.

General disclaimer:

The designations employed and the presentation of material on this map do not imply the expression of any opinion on the part of the World Economic Forum concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries.